Welcome to Living PAH

Pulmonary arterial hypertension (PAH) is a rare form of pulmonary hypertension that is estimated to affect about 140,000 people worldwide.1 Although it was once a diagnosis that offered little hope, the understanding of this disease and the number of treatment options has grown rapidly over the past two decades. PAH-specific treatment has advanced from one treatment in 1996, to nine FDA-approved treatment options available today, with many more in clinical development.2 Each day brings advancements in treatment, better diagnostic tools and new hope for people living with PAH.2, 3

Living PAH is dedicated to empowering people who are living with PAH and their loved ones by providing the most up-to-date information on the disease and treatment, along with a variety of support services, to help manage the challenges of living with PAH.

Questions? Call the Living PAH call center day or night for answers:
1-877-948-9137

Leaving LivingPAH.com

You have just clicked on a link that will take you outside the Living PAH website. United Therapeutics Corporation does not monitor, does not imply any endorsement, and is not responsible for the content on outside websites.

Click "OK" to proceed to this third-party website or "CANCEL" to return to LivingPAH.com.

You are now leaving the Living PAH website.

Click here to continue
Click here to return to livingPAH.com
close